TPG GP A, LLC purchased 60.4% of their position (1.39M shares) of ODYSSEY THERAPEUTICS, INC. on the open market
Open‑market purchase worth $25.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/13/2026ACC: 0001999371-26-010652
-15.01M
Net shares
Net seller
$42.3K
Total sold
1
Open market trades
1B · 0S
6
Total transactions
3.69M acquired · 18.70M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+423.11K
Price / share
—
Trade value
—
% of position
New position
5/11/2026
0.00→423.11K
Common Stock
Indirect
Shares
−2.35K
Price / share
$18.00
Trade value
$42.32K
% of position
0.6%
5/11/2026
423.11K→420.76K
Common Stock
Indirect
Shares
+1.88M
Price / share
—
Trade value
—
% of position
446.9%
5/11/2026
420.76K→2.30M
Common Stock
Indirect
Shares
+1.39M
Price / share
$18.00
Trade value
$25M
% of position
60.4%
5/11/2026
2.30M→3.69M
Total
Net shares
+3.69M
Net value
$24.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/11/2026 | J · J | +423.11K | — | — | New position | 0.00 | 423.11K |
| Common Stock Indirect | 5/11/2026 | J · J | −2.35K | $18.00 | $42.32K | 0.6% | 423.11K | 420.76K |
| Common Stock Indirect | 5/11/2026 | C · Conversion | +1.88M | — | — | 446.9% | 420.76K | 2.30M |
| Common Stock Indirect | 5/11/2026 | P · Purchase | +1.39M | $18.00 | $25M | 60.4% | 2.30M | 3.69M |
| Total | +3.69M | $24.96M | ||||||
Derivative Transactions2
Warrants (right to buy)
Indirect
Converts to
Common Stock
423.11K shares
Shares
−423.11K
Strike price
Held after
0.00
Exercisable
—
5/11/2026
Series D Preferred Stock
Indirect
Converts to
Common Stock
1.88M shares
Shares
−18.27M
Strike price
Held after
0.00
Exercisable
—
5/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to buy) Indirect | Common Stock423.11K shares | 5/11/2026 | J · J | −423.11K | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock1.88M shares | 5/11/2026 | C · Conversion | −18.27M | — | 0.00 |